Inventor · disambiguated record
Peter J. Manley
Also filed as: MANLEY PETER · MANLEY PETER J
25 granted patents·10 pending applications·426 citations·filing 1999–2024
95Inventor score
Files withMERCK SHARP & DOHME10MERCK & CO INC7MERCK SHARP & DOHME LLC4SMITHKLINE BEECHAM CORP4WOLKENBERG SCOTT2
Top patents by PatentIndex Score
35 records- 0196US6586423B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·151 cites·8 claims
- 0295US6586424B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jul 1, 2003·95 cites·8 claims
- 0392US7223738B2Inhibitors of Akt activityMERCK & CO INC·Filed 2003·Granted May 29, 2007·38 cites·9 claims
- 0491US6958340B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Oct 25, 2005·73 cites·12 claims
- 0587US7544677B2Inhibitors of Akt activityMERCK & CO INC·Filed 2005·Granted Jun 9, 2009·13 cites·7 claims
- 0685US7750151B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Jul 6, 2010·10 cites·2 claims
- 0783US7115597B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2003·Granted Oct 3, 2006·19 cites·31 claims
- 0881US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 0980US11198687B2Heteroaryl allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME·Filed 2018·Granted Dec 14, 2021·3 cites·13 claims
- 1077US7910561B2Inhibitors of Akt activityMERCK SHARP & DOHME·Filed 2005·Granted Mar 22, 2011·3 cites·4 claims
- 1176US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 1276US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 1376US7879839B2Potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·2 cites·5 claims
- 1472US8389720B2Quinolone neuropeptide S receptor antagonistsBARROW JAMES C·Filed 2009·Granted Mar 5, 2013·1 cites·8 claims
- 1570US6881736B1Vitronectin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 19, 2005·4 cites·6 claims
- 1667US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 1766US2024390471A1Compounds and adjuvant formulations useful in pneumococcal vaccinesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1865US9024032B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted May 5, 2015·1 cites·86 claims
- 1965US8541595B2Imidazoisoindole neuropeptide S receptor antagonistsMANLEY PETER J·Filed 2009·Granted Sep 24, 2013·1 cites·4 claims
- 2064US9309199B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted Apr 12, 2016·1 cites·16 claims
- 2160US9102673B2Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitorsHANNEY BARBARA·Filed 2012·Granted Aug 11, 2015·1 cites·14 claims
- 2258US2025066323A1Inhibitors of human respiratory syncytial virus and metapneumovirusMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2352US2023391795A1Macrocyclic urea orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2452US2023365531A1Inhibitors of human respiratory syncytial virus and metapneumo virusMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2549US2024101555A1Urea orexin receptor agonistsARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 2646US7569589B2Potassium channel inhibitorsMERCK & CO INC·Filed 2005·Granted Aug 4, 2009·0 cites·13 claims
- 2746US2010099673A1Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseasesBILODEAU MARK T·Filed 2008·Application pending·0 cites
- 2845US2002137755A1Tyrosine kinase inhibitorsFiled 2001·Application pending·0 cites
- 2941US8148535B2Potassium channel inhibitorsTROTTER B WESLEY·Filed 2006·Granted Apr 3, 2012·0 cites·8 claims
- 3041US2004235867A1Tyrosine kinase inhibitorsFiled 2002·Application pending·0 cites
- 3140US9399651B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersMERCK SHARP & DOHME·Filed 2015·Granted Jul 26, 2016·0 cites·41 claims
- 3240US2002147334A1Vitronectin Receptor AntagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 3338US2018305332A1Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their UseMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 3435US6495560B1Vitronectin receptor antagonistSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 17, 2002·1 cites·17 claims
- 3531US6458814B1Vitronectin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Oct 1, 2002·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Peter J. Manley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →